Olivieri Claudio, Crocoli Alessandro, De Pasquale Maria D, Inserra Alessandro
Division of Pediatric, General and Thoracic Surgery, Bambino Gesù Children's Hospital, Rome, Italy -
Minerva Pediatr. 2016 Dec;68(6):398-403. Epub 2015 Mar 18.
The use of central venous catheter (CVC) is essential in the management of chronically ill children. Thrombocytopenia is a common hematological finding in these patients, with an increased risk of bleeding during the insertion of CVC. No clear guidelines are reported regarding the CVC positioning in patients with disorders of hemostasis, and prophylactic platelet (PLT) transfusions are still controversial. Aim of this study was to report the bleeding risk in pediatric patients with thrombocytopenia who underwent positioning of CVC.
A retrospective single-center study of all CVCs surgically inserted over a 2-year period (April 2011 - April 2013) at our institution was performed. Age, gender, diagnosis, type of CVC, hematological values (hemoglobin and PLT count, prothrombin international normalized ratio, active partial thromboplastin time) and post-operative bleeding complications were compared between patients with PLT count below (group A) and above 50×109/L (group B).
Seventy-two CVC procedures were performed in 67 patients, with a median age of 45 months. Of these, 25 (35%) catheters were positioned in 25 patients included in group A and the remaining 47 (65%) in 42 patients in group B. All twenty-five cases in group A received a prophylactic PLT transfusion prior to the procedure. Bleeding complications were reported in only two cases in group A (8%).
CVC placement in pediatric patients with thrombocytopenia can be safely performed. We believe a randomized multicenter study could be necessary to determine the benefit of PLT transfusions in children with a PLT count below the recommended level of 50×109/L.
中心静脉导管(CVC)的使用在慢性病患儿的治疗中至关重要。血小板减少症是这些患者常见的血液学表现,在插入CVC期间出血风险增加。关于止血障碍患者的CVC置管,尚无明确的指南报道,预防性血小板(PLT)输注仍存在争议。本研究的目的是报告接受CVC置管的血小板减少症儿科患者的出血风险。
对我院在2年期间(2011年4月至2013年4月)手术插入的所有CVC进行回顾性单中心研究。比较血小板计数低于(A组)和高于50×10⁹/L(B组)的患者的年龄、性别、诊断、CVC类型、血液学指标(血红蛋白和PLT计数、凝血酶原国际标准化比值、活化部分凝血活酶时间)及术后出血并发症。
67例患者共进行了72次CVC操作,中位年龄为45个月。其中,25根(35%)导管插入A组的25例患者,其余47根(65%)插入B组的42例患者。A组的所有25例患者在操作前均接受了预防性PLT输注。A组仅2例(8%)报告有出血并发症。
血小板减少症儿科患者的CVC置管可安全进行。我们认为可能有必要进行一项随机多中心研究,以确定血小板计数低于推荐水平50×10⁹/L的儿童输注PLT的益处。